763P Re-VOLVE: Phase II trial in women with ovarian cancer progressing post-PARP-inhibitor with treatment adapted to real-time assessment of evolving genomic resistance.
Saved in:
| Title: | 763P Re-VOLVE: Phase II trial in women with ovarian cancer progressing post-PARP-inhibitor with treatment adapted to real-time assessment of evolving genomic resistance. |
|---|---|
| Authors: | Soberanis Pina, P.D.1 (AUTHOR), Oza, A.M.2 (AUTHOR), Dhani, N.3 (AUTHOR), Wang, L.4 (AUTHOR), Grant, R.5 (AUTHOR), Garg, V.1 (AUTHOR), Lee, J-S.6 (AUTHOR), Benito, C.7 (AUTHOR), Selim, F.R.8 (AUTHOR), Arora, S.9 (AUTHOR), Ramsahai, J.10 (AUTHOR), Quintos, J.11 (AUTHOR), Dhanabalan, P.12 (AUTHOR), Bowering, V.13 (AUTHOR), Lam, B.14 (AUTHOR), Thiagarajah, M.15 (AUTHOR), Fortuna, A.15 (AUTHOR), Pugh, T.16 (AUTHOR), Lheureux, S.3 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS577-S578. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179692221 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 763P Re-VOLVE: Phase II trial in women with ovarian cancer progressing post-PARP-inhibitor with treatment adapted to real-time assessment of evolving genomic resistance. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Soberanis+Pina%2C+P%2ED%2E%22">Soberanis Pina, P.D.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oza%2C+A%2EM%2E%22">Oza, A.M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dhani%2C+N%2E%22">Dhani, N.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+L%2E%22">Wang, L.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grant%2C+R%2E%22">Grant, R.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garg%2C+V%2E%22">Garg, V.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee%2C+J-S%2E%22">Lee, J-S.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Benito%2C+C%2E%22">Benito, C.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Selim%2C+F%2ER%2E%22">Selim, F.R.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Arora%2C+S%2E%22">Arora, S.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ramsahai%2C+J%2E%22">Ramsahai, J.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Quintos%2C+J%2E%22">Quintos, J.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dhanabalan%2C+P%2E%22">Dhanabalan, P.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bowering%2C+V%2E%22">Bowering, V.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lam%2C+B%2E%22">Lam, B.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thiagarajah%2C+M%2E%22">Thiagarajah, M.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fortuna%2C+A%2E%22">Fortuna, A.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pugh%2C+T%2E%22">Pugh, T.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lheureux%2C+S%2E%22">Lheureux, S.</searchLink><relatesTo>3</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS577-S578. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179692221 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.08.824 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S577 Titles: – TitleFull: 763P Re-VOLVE: Phase II trial in women with ovarian cancer progressing post-PARP-inhibitor with treatment adapted to real-time assessment of evolving genomic resistance. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Soberanis Pina, P.D. – PersonEntity: Name: NameFull: Oza, A.M. – PersonEntity: Name: NameFull: Dhani, N. – PersonEntity: Name: NameFull: Wang, L. – PersonEntity: Name: NameFull: Grant, R. – PersonEntity: Name: NameFull: Garg, V. – PersonEntity: Name: NameFull: Lee, J-S. – PersonEntity: Name: NameFull: Benito, C. – PersonEntity: Name: NameFull: Selim, F.R. – PersonEntity: Name: NameFull: Arora, S. – PersonEntity: Name: NameFull: Ramsahai, J. – PersonEntity: Name: NameFull: Quintos, J. – PersonEntity: Name: NameFull: Dhanabalan, P. – PersonEntity: Name: NameFull: Bowering, V. – PersonEntity: Name: NameFull: Lam, B. – PersonEntity: Name: NameFull: Thiagarajah, M. – PersonEntity: Name: NameFull: Fortuna, A. – PersonEntity: Name: NameFull: Pugh, T. – PersonEntity: Name: NameFull: Lheureux, S. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Supplement 2 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
